Molecularly targeted treatment for dermatofibrosarcoma protuberans
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 31, 30-36
- https://doi.org/10.1053/j.seminoncol.2004.03.038
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- PDGFRA Activating Mutations in Gastrointestinal Stromal TumorsScience, 2003
- Pharmacology of imatinib (STI571)European Journal Of Cancer, 2002
- Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor β receptor fusion oncogeneBlood, 2002
- Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberansInternational Journal of Cancer, 2002
- Imatinib Mesylate — A New Oral Targeted TherapyNew England Journal of Medicine, 2002
- Dermatofibrosarcoma protuberansCancer, 2000
- The Role of Radiation Therapy in the Management of Dermatofibrosarcoma ProtuberansInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Dermatofibrosarcoma protuberansJournal of the American Academy of Dermatology, 1996
- Dermatofibrosarcoma Protuberans of the Chest and the ShoulderPlastic and Reconstructive Surgery, 1993